Swiss National Bank

Bank

Position in ELVN — Enliven Therapeutics, Inc.

CIK 1582202 ZURICH, V8

Position in ELVN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$4,799,579

+$2,280,078 QoQ

Shares Held

94,573

+47.1% QoQ

Ownership

0.129%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#80

of 210 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. ELVN ranks #59 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	717,440	$356,373,971
2	REGN	Regeneron Pharmaceuticals, Inc.	293,020	$182,709,690
3	ALNY	Alnylam Pharmaceuticals, Inc.	374,080	$112,609,302
4	RVMD	Revolution Medicines, Inc.	456,331	$85,461,669
5	RPRX	Royalty Pharma plc	1,159,800	$65,029,986
6	INSM	INSMED Inc	593,512	$63,280,249
7	INCY	Incyte Corp	476,874	$54,058,436
8	MRNA	Moderna, Inc.	679,900	$47,613,397

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,799,579	94,573	+47.1%	Shares	Sole	2026-08-11
2026-03-31	$2,519,501	64,273	0.0%	Shares	Sole	2026-05-07
2025-12-31	$989,804	64,273	+1.7%	Shares	Sole	2026-02-12
2025-09-30	$1,293,151	63,173	+2.1%	Shares	Sole	2025-11-13
2025-06-30	$1,241,172	61,873	+47.8%	Shares	Sole	2025-08-12
2025-03-31	$824,060	41,873	0.0%	Shares	Sole	2025-05-12
2024-12-31	$942,142	41,873	+13.9%	Shares	Sole	2025-02-10
2024-09-30	$939,182	36,773	0.0%	Shares	Sole	2024-11-07
2024-06-30	$859,385	36,773	0.0%	Shares	Sole	2024-08-08
2024-03-31	$646,837	36,773	+0.8%	Shares	Sole	2024-05-07
2023-12-31	$504,786	36,473	-10.3%	Shares	Sole	2024-02-06
2023-09-30	$555,593	40,673	-17.3%	Shares	Sole	2023-11-08
2023-06-30	$1,003,620	49,173	—	Shares	Sole	2023-08-09
No filing history on record for this holder in this stock.